Related Experiment Video

Updated: Feb 21, 2026

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.8K

Regulation of signaling pathways by tanshinones in different cancers

X Lin1, M Z Qureshi2, M A Romero3

  • 1Department of Pharmacology, Pharmaceutical College, Southwest Medical University, Luzhou 646000, China.

Cellular and Molecular Biology (Noisy-Le-Grand, France)
|October 6, 2017
PubMed

Insights

Tanshinones, natural compounds, are emerging as key regulators in cancer. They target multiple signaling pathways, offering potential for personalized cancer medicine and overcoming therapeutic resistance.

Area of Science:

  • Molecular Oncology
  • Translational Regulation
  • Natural Product Research

Background:

  • Cancer development involves complex rewiring of gene expression at the translational level.
  • Technological advancements are revealing novel regulatory mechanisms in cancer progression, apoptosis evasion, and therapeutic resistance.

Purpose of the Study:

  • To explore the role of natural products, specifically Tanshinones, in modulating cancer-related signaling pathways.
  • To investigate how Tanshinones can be leveraged for personalized cancer medicine.

Main Methods:

  • Analysis of signaling pathways targeted by Tanshinones.
  • Investigation of Tanshinones' effects on JAK-STAT, ER stress, PI3K/AKT/mTOR, autophagy, and TRAIL pathways.
  • Exploration of Tanshinones' impact on microRNA regulation in cancer.

Main Results:

  • Tanshinones demonstrate the ability to target critical cancer signaling cascades.
  • These natural compounds show potential in modulating apoptosis and overcoming drug resistance.
  • Insights into Tanshinone-mediated regulation of microRNAs are being uncovered.

Conclusions:

  • Tanshinones represent a promising class of natural products for cancer therapy.
  • Targeting multiple pathways with Tanshinones could lead to more effective and personalized cancer treatments.
  • Further research into Tanshinones will advance the development of novel therapeutic strategies.
Keywords:
Apoptosis.CancerSignalingTRAILTanshinones

More Related Videos

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.4K
Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula09:03

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Published on: January 26, 2024

734

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.7K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.9K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.1K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.7K